Could a simple scan replace kidney biopsies? new study tests a tracer that sees scarring

NCT ID NCT07712679

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study explores whether a special PET/CT scan using a tracer called 68Ga-FAPI can detect fibrosis (scarring) in the kidneys of people with chronic kidney disease. Currently, scarring can only be confirmed through a kidney biopsy, which is invasive and can miss areas of damage. The researchers will compare the scan results with biopsy findings to see if the imaging method accurately reflects the amount of fibrosis. If it works, this could lead to a safer, more complete way to monitor kidney disease progression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
68Ga-FAPI tracer for PET/CT imaging
What this could lead to
If successful, this imaging method could allow doctors to assess kidney scarring without an invasive biopsy, improving monitoring of chronic kidney disease.
What could go wrong
This is a small pilot study with only 30 participants, so results may not apply broadly. The tracer's accuracy in detecting fibrosis is still unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • General hospital Vienna

    RECRUITING

    Vienna, State of Vienna, 1090, Austria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.